Alkem launches Ibuprofen, Famotidine tablets

The launch is a subject of ongoing litigation

Picture: Pixabay

Last Updated on August 6, 2021 by The Health Master

Alkem Laboratories has launched Ibuprofen and Famotidine tablets, used to relieve the symptoms of rheumatoid arthritis and osteoarthritis, in the US market, a company statement said.

It also said that Ibuprofen and Famotidine tablets are a generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis tablets.

The company has launched Ibuprofen and Famotidine tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the United States Food and Drug Administration (USFDA), added the statement.

It further said that this is the first generic approval of Duexis tablets, 800 mg/26.6 mg by the USFDA.

“The launch is a subject of ongoing litigation,” it added.

Zydus Cadila gets final nod from USFDA for Fulvestrant injection

USFDA inspection ends with ‘Zero’ observations: Alkem

Granules Pharma clears USFDA audit

Zydus Cadila gets USFDA nod for Ibrutinib tablets

Lupin gets USFDA nod for generic Antifungal drug

Unichem gets tentative USFDA nod for drug to treat Diabetes

7 Tips Every Men Should Follow In Healthy Skincare Regime

India and Pharmacy Education: Chapter: 3

Report of Govt Analyst and CDL must give factual data (Part-2)

Govt grants Rs 100cr for Medical Device Park

Indian medical devices industry all set to flourish: Experts

New Medicine for Drug resistant TB patients


Enter your email address:

Delivered by FeedBurner